nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfacetamide—Mafenide—CA9—hematologic cancer	0.00475	0.178	CrCbGaD
Sulfacetamide—Gliclazide—VEGFA—hematologic cancer	0.00279	0.104	CrCbGaD
Sulfacetamide—Toxic epidermal necrolysis—Ifosfamide—hematologic cancer	0.0025	0.00256	CcSEcCtD
Sulfacetamide—Oedema—Teniposide—hematologic cancer	0.00247	0.00254	CcSEcCtD
Sulfacetamide—Hypersensitivity—Mechlorethamine—hematologic cancer	0.00247	0.00254	CcSEcCtD
Sulfacetamide—Erythema—Nilotinib—hematologic cancer	0.00247	0.00254	CcSEcCtD
Sulfacetamide—Infection—Teniposide—hematologic cancer	0.00246	0.00253	CcSEcCtD
Sulfacetamide—Erythema—Imatinib—hematologic cancer	0.00245	0.00252	CcSEcCtD
Sulfacetamide—Pain—Nelarabine—hematologic cancer	0.00242	0.00249	CcSEcCtD
Sulfacetamide—Erythema—Cladribine—hematologic cancer	0.00241	0.00248	CcSEcCtD
Sulfacetamide—Pruritus—Mechlorethamine—hematologic cancer	0.00237	0.00244	CcSEcCtD
Sulfacetamide—Acetaminophen—UGT1A1—hematologic cancer	0.00236	0.0882	CrCbGaD
Sulfacetamide—Blister—Epirubicin—hematologic cancer	0.00235	0.00241	CcSEcCtD
Sulfacetamide—Erythema multiforme—Lenalidomide—hematologic cancer	0.00232	0.00239	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Gemcitabine—hematologic cancer	0.00231	0.00237	CcSEcCtD
Sulfacetamide—Agranulocytosis—Vinorelbine—hematologic cancer	0.0023	0.00236	CcSEcCtD
Sulfacetamide—Oedema—Busulfan—hematologic cancer	0.00229	0.00236	CcSEcCtD
Sulfacetamide—Infection—Busulfan—hematologic cancer	0.00228	0.00234	CcSEcCtD
Sulfacetamide—Probenecid—ABCC3—hematologic cancer	0.00228	0.0851	CrCbGaD
Sulfacetamide—Pain—Daunorubicin—hematologic cancer	0.00227	0.00233	CcSEcCtD
Sulfacetamide—Pain—Clofarabine—hematologic cancer	0.00227	0.00233	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Prednisolone—hematologic cancer	0.00226	0.00232	CcSEcCtD
Sulfacetamide—Pain—Pentostatin—hematologic cancer	0.00226	0.00232	CcSEcCtD
Sulfacetamide—Pain—Anagrelide—hematologic cancer	0.00226	0.00232	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Thalidomide—hematologic cancer	0.00225	0.00231	CcSEcCtD
Sulfacetamide—Oedema—Procarbazine—hematologic cancer	0.00222	0.00229	CcSEcCtD
Sulfacetamide—Infection—Procarbazine—hematologic cancer	0.00221	0.00227	CcSEcCtD
Sulfacetamide—Agranulocytosis—Thiotepa—hematologic cancer	0.00219	0.00225	CcSEcCtD
Sulfacetamide—Oedema—Bexarotene—hematologic cancer	0.00218	0.00224	CcSEcCtD
Sulfacetamide—Oedema—Dasatinib—hematologic cancer	0.00218	0.00224	CcSEcCtD
Sulfacetamide—Oedema—Fludarabine—hematologic cancer	0.00217	0.00223	CcSEcCtD
Sulfacetamide—Blister—Doxorubicin—hematologic cancer	0.00217	0.00223	CcSEcCtD
Sulfacetamide—Infection—Bexarotene—hematologic cancer	0.00217	0.00223	CcSEcCtD
Sulfacetamide—Infection—Dasatinib—hematologic cancer	0.00217	0.00223	CcSEcCtD
Sulfacetamide—Infection—Fludarabine—hematologic cancer	0.00216	0.00222	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Alitretinoin—hematologic cancer	0.00214	0.0022	CcSEcCtD
Sulfacetamide—Erythema—Lenalidomide—hematologic cancer	0.00214	0.0022	CcSEcCtD
Sulfacetamide—Erythema multiforme—Bortezomib—hematologic cancer	0.00214	0.0022	CcSEcCtD
Sulfacetamide—Agranulocytosis—Thalidomide—hematologic cancer	0.00212	0.00218	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Ifosfamide—hematologic cancer	0.00212	0.00218	CcSEcCtD
Sulfacetamide—Erythema—Hydroxyurea—hematologic cancer	0.00211	0.00217	CcSEcCtD
Sulfacetamide—Stinging—Epirubicin—hematologic cancer	0.00209	0.00214	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Triamcinolone—hematologic cancer	0.00208	0.00213	CcSEcCtD
Sulfacetamide—Infection—Chlorambucil—hematologic cancer	0.00205	0.0021	CcSEcCtD
Sulfacetamide—Hypersensitivity—Methoxsalen—hematologic cancer	0.00204	0.00209	CcSEcCtD
Sulfacetamide—Blood disorder—Epirubicin—hematologic cancer	0.00202	0.00208	CcSEcCtD
Sulfacetamide—Agranulocytosis—Alitretinoin—hematologic cancer	0.00202	0.00207	CcSEcCtD
Sulfacetamide—Oedema—Nilotinib—hematologic cancer	0.00201	0.00207	CcSEcCtD
Sulfacetamide—Oedema—Imatinib—hematologic cancer	0.002	0.00206	CcSEcCtD
Sulfacetamide—Infection—Nilotinib—hematologic cancer	0.002	0.00206	CcSEcCtD
Sulfacetamide—Agranulocytosis—Ifosfamide—hematologic cancer	0.00199	0.00205	CcSEcCtD
Sulfacetamide—Infection—Imatinib—hematologic cancer	0.00199	0.00204	CcSEcCtD
Sulfacetamide—Hypersensitivity—Mercaptopurine—hematologic cancer	0.00198	0.00203	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Etoposide—hematologic cancer	0.00197	0.00203	CcSEcCtD
Sulfacetamide—Erythema—Bortezomib—hematologic cancer	0.00197	0.00202	CcSEcCtD
Sulfacetamide—Oedema—Cladribine—hematologic cancer	0.00197	0.00202	CcSEcCtD
Sulfacetamide—Pain—Busulfan—hematologic cancer	0.00196	0.00201	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Gemcitabine—hematologic cancer	0.00196	0.00201	CcSEcCtD
Sulfacetamide—Pruritus—Methoxsalen—hematologic cancer	0.00196	0.00201	CcSEcCtD
Sulfacetamide—Infection—Cladribine—hematologic cancer	0.00196	0.00201	CcSEcCtD
Sulfacetamide—Erythema—Bleomycin—hematologic cancer	0.00195	0.00201	CcSEcCtD
Sulfacetamide—Hypersensitivity—Clofarabine—hematologic cancer	0.00195	0.00201	CcSEcCtD
Sulfacetamide—Hypersensitivity—Daunorubicin—hematologic cancer	0.00195	0.00201	CcSEcCtD
Sulfacetamide—Hypersensitivity—Pentostatin—hematologic cancer	0.00194	0.002	CcSEcCtD
Sulfacetamide—Stinging—Doxorubicin—hematologic cancer	0.00193	0.00198	CcSEcCtD
Sulfacetamide—Erythema multiforme—Thalidomide—hematologic cancer	0.00193	0.00198	CcSEcCtD
Sulfacetamide—Erythema—Vinorelbine—hematologic cancer	0.00192	0.00197	CcSEcCtD
Sulfacetamide—Pain—Procarbazine—hematologic cancer	0.0019	0.00195	CcSEcCtD
Sulfacetamide—Agranulocytosis—Mitoxantrone—hematologic cancer	0.00189	0.00195	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Dexamethasone—hematologic cancer	0.00189	0.00194	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Betamethasone—hematologic cancer	0.00189	0.00194	CcSEcCtD
Sulfacetamide—Pruritus—Clofarabine—hematologic cancer	0.00187	0.00193	CcSEcCtD
Sulfacetamide—Pruritus—Daunorubicin—hematologic cancer	0.00187	0.00193	CcSEcCtD
Sulfacetamide—Hypersensitivity—Idarubicin—hematologic cancer	0.00187	0.00193	CcSEcCtD
Sulfacetamide—Blood disorder—Doxorubicin—hematologic cancer	0.00187	0.00192	CcSEcCtD
Sulfacetamide—Pruritus—Anagrelide—hematologic cancer	0.00187	0.00192	CcSEcCtD
Sulfacetamide—Pruritus—Pentostatin—hematologic cancer	0.00187	0.00192	CcSEcCtD
Sulfacetamide—Pain—Bexarotene—hematologic cancer	0.00186	0.00192	CcSEcCtD
Sulfacetamide—Pain—Dasatinib—hematologic cancer	0.00186	0.00192	CcSEcCtD
Sulfacetamide—Pain—Fludarabine—hematologic cancer	0.00186	0.00191	CcSEcCtD
Sulfacetamide—Agranulocytosis—Gemcitabine—hematologic cancer	0.00184	0.00189	CcSEcCtD
Sulfacetamide—Erythema—Thiotepa—hematologic cancer	0.00184	0.00189	CcSEcCtD
Sulfacetamide—Erythema multiforme—Alitretinoin—hematologic cancer	0.00183	0.00189	CcSEcCtD
Sulfacetamide—Hypersensitivity—Teniposide—hematologic cancer	0.00182	0.00187	CcSEcCtD
Sulfacetamide—Erythema multiforme—Ifosfamide—hematologic cancer	0.00181	0.00186	CcSEcCtD
Sulfacetamide—Oedema—Melphalan—hematologic cancer	0.0018	0.00184	CcSEcCtD
Sulfacetamide—Infection—Melphalan—hematologic cancer	0.00178	0.00183	CcSEcCtD
Sulfacetamide—Pain—Chlorambucil—hematologic cancer	0.00176	0.00181	CcSEcCtD
Sulfacetamide—Pruritus—Teniposide—hematologic cancer	0.00175	0.0018	CcSEcCtD
Sulfacetamide—Oedema—Lenalidomide—hematologic cancer	0.00175	0.00179	CcSEcCtD
Sulfacetamide—Infection—Lenalidomide—hematologic cancer	0.00173	0.00178	CcSEcCtD
Sulfacetamide—Pain—Nilotinib—hematologic cancer	0.00172	0.00177	CcSEcCtD
Sulfacetamide—Oedema—Hydroxyurea—hematologic cancer	0.00172	0.00177	CcSEcCtD
Sulfacetamide—Pain—Imatinib—hematologic cancer	0.00171	0.00176	CcSEcCtD
Sulfacetamide—Infection—Hydroxyurea—hematologic cancer	0.00171	0.00176	CcSEcCtD
Sulfacetamide—Erythema—Carmustine—hematologic cancer	0.00171	0.00175	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Methotrexate—hematologic cancer	0.0017	0.00174	CcSEcCtD
Sulfacetamide—Hypersensitivity—Busulfan—hematologic cancer	0.00169	0.00174	CcSEcCtD
Sulfacetamide—Erythema—Alitretinoin—hematologic cancer	0.00169	0.00174	CcSEcCtD
Sulfacetamide—Sulfanilamide—CA9—hematologic cancer	0.00169	0.0631	CrCbGaD
Sulfacetamide—Pain—Cladribine—hematologic cancer	0.00168	0.00173	CcSEcCtD
Sulfacetamide—Erythema multiforme—Gemcitabine—hematologic cancer	0.00168	0.00172	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Etoposide—hematologic cancer	0.00167	0.00172	CcSEcCtD
Sulfacetamide—Erythema—Ifosfamide—hematologic cancer	0.00167	0.00172	CcSEcCtD
Sulfacetamide—Hypersensitivity—Procarbazine—hematologic cancer	0.00164	0.00168	CcSEcCtD
Sulfacetamide—Pruritus—Busulfan—hematologic cancer	0.00162	0.00167	CcSEcCtD
Sulfacetamide—Pain—Vinblastine—hematologic cancer	0.00161	0.00166	CcSEcCtD
Sulfacetamide—Oedema—Bortezomib—hematologic cancer	0.00161	0.00165	CcSEcCtD
Sulfacetamide—Hypersensitivity—Bexarotene—hematologic cancer	0.00161	0.00165	CcSEcCtD
Sulfacetamide—Hypersensitivity—Dasatinib—hematologic cancer	0.00161	0.00165	CcSEcCtD
Sulfacetamide—Hypersensitivity—Fludarabine—hematologic cancer	0.0016	0.00165	CcSEcCtD
Sulfacetamide—Infection—Bortezomib—hematologic cancer	0.0016	0.00164	CcSEcCtD
Sulfacetamide—Oedema—Bleomycin—hematologic cancer	0.00159	0.00164	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Epirubicin—hematologic cancer	0.00159	0.00163	CcSEcCtD
Sulfacetamide—Erythema—Mitoxantrone—hematologic cancer	0.00159	0.00163	CcSEcCtD
Sulfacetamide—Infection—Bleomycin—hematologic cancer	0.00158	0.00163	CcSEcCtD
Sulfacetamide—Probenecid—SLC22A1—hematologic cancer	0.00158	0.0592	CrCbGaD
Sulfacetamide—Agranulocytosis—Etoposide—hematologic cancer	0.00157	0.00162	CcSEcCtD
Sulfacetamide—Pruritus—Procarbazine—hematologic cancer	0.00157	0.00162	CcSEcCtD
Sulfacetamide—Aminohippurate—SLC22A1—hematologic cancer	0.00156	0.0584	CrCbGaD
Sulfacetamide—Infection—Vinorelbine—hematologic cancer	0.00156	0.0016	CcSEcCtD
Sulfacetamide—Erythema—Gemcitabine—hematologic cancer	0.00154	0.00159	CcSEcCtD
Sulfacetamide—Pruritus—Bexarotene—hematologic cancer	0.00154	0.00159	CcSEcCtD
Sulfacetamide—Pruritus—Dasatinib—hematologic cancer	0.00154	0.00159	CcSEcCtD
Sulfacetamide—Pruritus—Fludarabine—hematologic cancer	0.00154	0.00158	CcSEcCtD
Sulfacetamide—Pain—Melphalan—hematologic cancer	0.00154	0.00158	CcSEcCtD
Sulfacetamide—Hypersensitivity—Chlorambucil—hematologic cancer	0.00152	0.00156	CcSEcCtD
Sulfacetamide—Pain—Lenalidomide—hematologic cancer	0.00149	0.00153	CcSEcCtD
Sulfacetamide—Infection—Thiotepa—hematologic cancer	0.00149	0.00153	CcSEcCtD
Sulfacetamide—Hypersensitivity—Nilotinib—hematologic cancer	0.00148	0.00153	CcSEcCtD
Sulfacetamide—Hypersensitivity—Imatinib—hematologic cancer	0.00148	0.00152	CcSEcCtD
Sulfacetamide—Pain—Hydroxyurea—hematologic cancer	0.00147	0.00151	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Doxorubicin—hematologic cancer	0.00147	0.00151	CcSEcCtD
Sulfacetamide—Pruritus—Chlorambucil—hematologic cancer	0.00146	0.0015	CcSEcCtD
Sulfacetamide—Hypersensitivity—Cladribine—hematologic cancer	0.00145	0.00149	CcSEcCtD
Sulfacetamide—Oedema—Thalidomide—hematologic cancer	0.00145	0.00149	CcSEcCtD
Sulfacetamide—Infection—Thalidomide—hematologic cancer	0.00144	0.00148	CcSEcCtD
Sulfacetamide—Erythema—Cisplatin—hematologic cancer	0.00144	0.00148	CcSEcCtD
Sulfacetamide—Erythema multiforme—Etoposide—hematologic cancer	0.00143	0.00147	CcSEcCtD
Sulfacetamide—Pruritus—Nilotinib—hematologic cancer	0.00143	0.00146	CcSEcCtD
Sulfacetamide—Pruritus—Imatinib—hematologic cancer	0.00142	0.00146	CcSEcCtD
Sulfacetamide—Pruritus—Cladribine—hematologic cancer	0.00139	0.00143	CcSEcCtD
Sulfacetamide—Oedema—Carmustine—hematologic cancer	0.00139	0.00143	CcSEcCtD
Sulfacetamide—Hypersensitivity—Vinblastine—hematologic cancer	0.00139	0.00143	CcSEcCtD
Sulfacetamide—Infection—Carmustine—hematologic cancer	0.00138	0.00142	CcSEcCtD
Sulfacetamide—Oedema—Alitretinoin—hematologic cancer	0.00138	0.00142	CcSEcCtD
Sulfacetamide—Pain—Bortezomib—hematologic cancer	0.00137	0.00141	CcSEcCtD
Sulfacetamide—Infection—Alitretinoin—hematologic cancer	0.00137	0.00141	CcSEcCtD
Sulfacetamide—Pain—Bleomycin—hematologic cancer	0.00136	0.0014	CcSEcCtD
Sulfacetamide—Oedema—Ifosfamide—hematologic cancer	0.00136	0.0014	CcSEcCtD
Sulfacetamide—Infection—Ifosfamide—hematologic cancer	0.00135	0.00139	CcSEcCtD
Sulfacetamide—Pain—Vinorelbine—hematologic cancer	0.00134	0.00138	CcSEcCtD
Sulfacetamide—Oedema—Vincristine—hematologic cancer	0.00133	0.00136	CcSEcCtD
Sulfacetamide—Hypersensitivity—Melphalan—hematologic cancer	0.00132	0.00136	CcSEcCtD
Sulfacetamide—Infection—Vincristine—hematologic cancer	0.00132	0.00136	CcSEcCtD
Sulfacetamide—Erythema—Prednisolone—hematologic cancer	0.0013	0.00134	CcSEcCtD
Sulfacetamide—Oedema—Irinotecan—hematologic cancer	0.00129	0.00133	CcSEcCtD
Sulfacetamide—Oedema—Mitoxantrone—hematologic cancer	0.00129	0.00133	CcSEcCtD
Sulfacetamide—Hypersensitivity—Lenalidomide—hematologic cancer	0.00129	0.00132	CcSEcCtD
Sulfacetamide—Infection—Mitoxantrone—hematologic cancer	0.00129	0.00132	CcSEcCtD
Sulfacetamide—Infection—Irinotecan—hematologic cancer	0.00129	0.00132	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Epirubicin—hematologic cancer	0.00128	0.00132	CcSEcCtD
Sulfacetamide—Pain—Thiotepa—hematologic cancer	0.00128	0.00132	CcSEcCtD
Sulfacetamide—Pruritus—Melphalan—hematologic cancer	0.00127	0.00131	CcSEcCtD
Sulfacetamide—Hypersensitivity—Hydroxyurea—hematologic cancer	0.00127	0.0013	CcSEcCtD
Sulfacetamide—Oedema—Gemcitabine—hematologic cancer	0.00126	0.00129	CcSEcCtD
Sulfacetamide—Infection—Gemcitabine—hematologic cancer	0.00125	0.00129	CcSEcCtD
Sulfacetamide—Pain—Thalidomide—hematologic cancer	0.00124	0.00127	CcSEcCtD
Sulfacetamide—Pruritus—Lenalidomide—hematologic cancer	0.00124	0.00127	CcSEcCtD
Sulfacetamide—Procainamide—SLC22A1—hematologic cancer	0.00122	0.0455	CrCbGaD
Sulfacetamide—Erythema—Triamcinolone—hematologic cancer	0.0012	0.00123	CcSEcCtD
Sulfacetamide—Pain—Carmustine—hematologic cancer	0.00119	0.00122	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Doxorubicin—hematologic cancer	0.00119	0.00122	CcSEcCtD
Sulfacetamide—Hypersensitivity—Bortezomib—hematologic cancer	0.00118	0.00122	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Methotrexate—hematologic cancer	0.00118	0.00121	CcSEcCtD
Sulfacetamide—Pain—Alitretinoin—hematologic cancer	0.00118	0.00121	CcSEcCtD
Sulfacetamide—Oedema—Cisplatin—hematologic cancer	0.00117	0.00121	CcSEcCtD
Sulfacetamide—Hypersensitivity—Bleomycin—hematologic cancer	0.00117	0.00121	CcSEcCtD
Sulfacetamide—Infection—Cisplatin—hematologic cancer	0.00117	0.0012	CcSEcCtD
Sulfacetamide—Pain—Ifosfamide—hematologic cancer	0.00117	0.0012	CcSEcCtD
Sulfacetamide—Hypersensitivity—Vinorelbine—hematologic cancer	0.00116	0.00119	CcSEcCtD
Sulfacetamide—Sulfamethazine—ALB—hematologic cancer	0.00114	0.0425	CrCbGaD
Sulfacetamide—Pruritus—Bortezomib—hematologic cancer	0.00114	0.00117	CcSEcCtD
Sulfacetamide—Pain—Vincristine—hematologic cancer	0.00114	0.00117	CcSEcCtD
Sulfacetamide—Dapsone—MPO—hematologic cancer	0.00113	0.0423	CrCbGaD
Sulfacetamide—Pruritus—Bleomycin—hematologic cancer	0.00113	0.00116	CcSEcCtD
Sulfacetamide—Sulfamerazine—ALB—hematologic cancer	0.00111	0.0415	CrCbGaD
Sulfacetamide—Pruritus—Vinorelbine—hematologic cancer	0.00111	0.00114	CcSEcCtD
Sulfacetamide—Pain—Mitoxantrone—hematologic cancer	0.00111	0.00114	CcSEcCtD
Sulfacetamide—Pain—Irinotecan—hematologic cancer	0.00111	0.00114	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Epirubicin—hematologic cancer	0.00111	0.00114	CcSEcCtD
Sulfacetamide—Hypersensitivity—Thiotepa—hematologic cancer	0.0011	0.00113	CcSEcCtD
Sulfacetamide—Erythema—Dexamethasone—hematologic cancer	0.00109	0.00111	CcSEcCtD
Sulfacetamide—Erythema—Betamethasone—hematologic cancer	0.00109	0.00111	CcSEcCtD
Sulfacetamide—Pain—Gemcitabine—hematologic cancer	0.00108	0.00111	CcSEcCtD
Sulfacetamide—Infection—Etoposide—hematologic cancer	0.00107	0.0011	CcSEcCtD
Sulfacetamide—Hypersensitivity—Thalidomide—hematologic cancer	0.00107	0.0011	CcSEcCtD
Sulfacetamide—Oedema—Prednisolone—hematologic cancer	0.00106	0.00109	CcSEcCtD
Sulfacetamide—Pruritus—Thiotepa—hematologic cancer	0.00106	0.00109	CcSEcCtD
Sulfacetamide—Hypersensitivity—Carmustine—hematologic cancer	0.00103	0.00105	CcSEcCtD
Sulfacetamide—Pruritus—Thalidomide—hematologic cancer	0.00103	0.00105	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Doxorubicin—hematologic cancer	0.00102	0.00105	CcSEcCtD
Sulfacetamide—Hypersensitivity—Alitretinoin—hematologic cancer	0.00102	0.00104	CcSEcCtD
Sulfacetamide—Pain—Cisplatin—hematologic cancer	0.001	0.00103	CcSEcCtD
Sulfacetamide—Hypersensitivity—Ifosfamide—hematologic cancer	0.001	0.00103	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	0.001	0.00103	CcSEcCtD
Sulfacetamide—Hypersensitivity—Vincristine—hematologic cancer	0.000979	0.00101	CcSEcCtD
Sulfacetamide—Oedema—Triamcinolone—hematologic cancer	0.000976	0.001	CcSEcCtD
Sulfacetamide—Pruritus—Alitretinoin—hematologic cancer	0.000975	0.001	CcSEcCtD
Sulfacetamide—Infection—Triamcinolone—hematologic cancer	0.00097	0.000996	CcSEcCtD
Sulfacetamide—Pruritus—Ifosfamide—hematologic cancer	0.000964	0.00099	CcSEcCtD
Sulfacetamide—Hypersensitivity—Irinotecan—hematologic cancer	0.000953	0.000979	CcSEcCtD
Sulfacetamide—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000953	0.000979	CcSEcCtD
Sulfacetamide—Erythema—Prednisone—hematologic cancer	0.000945	0.000971	CcSEcCtD
Sulfacetamide—Agranulocytosis—Methotrexate—hematologic cancer	0.000943	0.000969	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	0.000938	0.000963	CcSEcCtD
Sulfacetamide—Pain—Etoposide—hematologic cancer	0.00092	0.000946	CcSEcCtD
Sulfacetamide—Pain—Prednisolone—hematologic cancer	0.000908	0.000933	CcSEcCtD
Sulfacetamide—Pruritus—Gemcitabine—hematologic cancer	0.000892	0.000916	CcSEcCtD
Sulfacetamide—Oedema—Dexamethasone—hematologic cancer	0.000886	0.00091	CcSEcCtD
Sulfacetamide—Oedema—Betamethasone—hematologic cancer	0.000886	0.00091	CcSEcCtD
Sulfacetamide—Agranulocytosis—Epirubicin—hematologic cancer	0.000883	0.000907	CcSEcCtD
Sulfacetamide—Infection—Dexamethasone—hematologic cancer	0.00088	0.000904	CcSEcCtD
Sulfacetamide—Infection—Betamethasone—hematologic cancer	0.00088	0.000904	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.000868	0.000891	CcSEcCtD
Sulfacetamide—Hypersensitivity—Cisplatin—hematologic cancer	0.000865	0.000889	CcSEcCtD
Sulfacetamide—Sulfamethizole—ALB—hematologic cancer	0.000861	0.0322	CrCbGaD
Sulfacetamide—Erythema multiforme—Methotrexate—hematologic cancer	0.000858	0.000881	CcSEcCtD
Sulfacetamide—Pain—Triamcinolone—hematologic cancer	0.000835	0.000858	CcSEcCtD
Sulfacetamide—Agranulocytosis—Doxorubicin—hematologic cancer	0.000817	0.000839	CcSEcCtD
Sulfacetamide—Erythema multiforme—Epirubicin—hematologic cancer	0.000803	0.000825	CcSEcCtD
Sulfacetamide—Hypersensitivity—Etoposide—hematologic cancer	0.000793	0.000815	CcSEcCtD
Sulfacetamide—Erythema—Methotrexate—hematologic cancer	0.00079	0.000811	CcSEcCtD
Sulfacetamide—Hypersensitivity—Prednisolone—hematologic cancer	0.000782	0.000803	CcSEcCtD
Sulfacetamide—Oedema—Prednisone—hematologic cancer	0.000771	0.000792	CcSEcCtD
Sulfacetamide—Infection—Prednisone—hematologic cancer	0.000766	0.000787	CcSEcCtD
Sulfacetamide—Pruritus—Etoposide—hematologic cancer	0.000761	0.000782	CcSEcCtD
Sulfacetamide—Pain—Betamethasone—hematologic cancer	0.000757	0.000778	CcSEcCtD
Sulfacetamide—Pain—Dexamethasone—hematologic cancer	0.000757	0.000778	CcSEcCtD
Sulfacetamide—Gliclazide—ALB—hematologic cancer	0.00075	0.0281	CrCbGaD
Sulfacetamide—Erythema multiforme—Doxorubicin—hematologic cancer	0.000743	0.000763	CcSEcCtD
Sulfacetamide—Erythema—Epirubicin—hematologic cancer	0.000739	0.000759	CcSEcCtD
Sulfacetamide—Hypersensitivity—Triamcinolone—hematologic cancer	0.000719	0.000739	CcSEcCtD
Sulfacetamide—Pruritus—Triamcinolone—hematologic cancer	0.000691	0.00071	CcSEcCtD
Sulfacetamide—Erythema—Doxorubicin—hematologic cancer	0.000684	0.000703	CcSEcCtD
Sulfacetamide—Infection—Methotrexate—hematologic cancer	0.00064	0.000658	CcSEcCtD
Sulfacetamide—Pruritus—Betamethasone—hematologic cancer	0.000627	0.000644	CcSEcCtD
Sulfacetamide—Pruritus—Dexamethasone—hematologic cancer	0.000627	0.000644	CcSEcCtD
Sulfacetamide—Oedema—Epirubicin—hematologic cancer	0.000603	0.00062	CcSEcCtD
Sulfacetamide—Infection—Epirubicin—hematologic cancer	0.000599	0.000616	CcSEcCtD
Sulfacetamide—Hypersensitivity—Prednisone—hematologic cancer	0.000568	0.000584	CcSEcCtD
Sulfacetamide—Oedema—Doxorubicin—hematologic cancer	0.000558	0.000573	CcSEcCtD
Sulfacetamide—Chlorpropamide—ABCB1—hematologic cancer	0.000557	0.0208	CrCbGaD
Sulfacetamide—Infection—Doxorubicin—hematologic cancer	0.000554	0.00057	CcSEcCtD
Sulfacetamide—Acetaminophen—ABCB1—hematologic cancer	0.000552	0.0206	CrCbGaD
Sulfacetamide—Pain—Methotrexate—hematologic cancer	0.000551	0.000566	CcSEcCtD
Sulfacetamide—Pruritus—Prednisone—hematologic cancer	0.000546	0.000561	CcSEcCtD
Sulfacetamide—Benzocaine—ABCB1—hematologic cancer	0.000543	0.0203	CrCbGaD
Sulfacetamide—Pain—Epirubicin—hematologic cancer	0.000516	0.00053	CcSEcCtD
Sulfacetamide—Sulfamethoxazole—ALB—hematologic cancer	0.000484	0.0181	CrCbGaD
Sulfacetamide—Probenecid—ALB—hematologic cancer	0.000482	0.018	CrCbGaD
Sulfacetamide—Pain—Doxorubicin—hematologic cancer	0.000477	0.00049	CcSEcCtD
Sulfacetamide—Hypersensitivity—Methotrexate—hematologic cancer	0.000475	0.000488	CcSEcCtD
Sulfacetamide—Probenecid—ABCB1—hematologic cancer	0.00046	0.0172	CrCbGaD
Sulfacetamide—Pruritus—Methotrexate—hematologic cancer	0.000456	0.000469	CcSEcCtD
Sulfacetamide—Aminohippurate—ABCB1—hematologic cancer	0.000454	0.017	CrCbGaD
Sulfacetamide—Hypersensitivity—Epirubicin—hematologic cancer	0.000444	0.000457	CcSEcCtD
Sulfacetamide—Pruritus—Epirubicin—hematologic cancer	0.000427	0.000439	CcSEcCtD
Sulfacetamide—Hypersensitivity—Doxorubicin—hematologic cancer	0.000411	0.000423	CcSEcCtD
Sulfacetamide—Pruritus—Doxorubicin—hematologic cancer	0.000395	0.000406	CcSEcCtD
